Davidson et al. (2019) demonstrated that PD1+CD8+ T cells in gliomas had elevated TCR clonality and decreased diversity, reflecting the activation of specific anti-tumor machinery within this cell population. The gene discussed is CD8A; the disease is central nervous system cancer.